Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Atorvastatin
Treatment for Chronic kidney disease due to diabetes mellitus type 1
Typical Dosage: 10-80mg daily
Effectiveness
80%
Safety Score
65%
Clinical Trials
500
Participants
500K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
10-80mg daily
Time to Effect
Weeks for lipid lowering, months to years for CV event reduction
Treatment Duration
Lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
30(Treat 30 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
100(Treat 100 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$50
Side Effect Mgmt:$20
Total Annual:$120
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$20,000/QALY
QALYs Gained
1
Outcome-Based Costs
Cost per Responder
$141
Atorvastatin Outcomes
for Chronic kidney disease due to diabetes mellitus type 1
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+85%
Common Side Effects
Myalgia/Muscle pain
+7%
GI upset
+4%
Liver enzyme elevation
+1%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov